Treatment of Tourette's syndrome with mecamylamine

Sanberg et al report that the antihypertensive agent mecamylamine improves the symptoms of Tourette's syndrome.

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 352; no. 9129; pp. 705 - 706
Main Authors Sanberg, Paul R, Shytle, R Douglas, Silver, Archie A
Format Journal Article
LanguageEnglish
Published London Elsevier Ltd 29.08.1998
Lancet
Elsevier Limited
Subjects
Adolescent
Adult
Biological and medical sciences
Drug therapy
Drugs
Female
Humans
Male
Mecamylamine - therapeutic use
Medical sciences
Miscellaneous
Neurological disorders
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Nicotinic Antagonists - therapeutic use
Pharmacology. Drug treatments
Retrospective Studies
Tourette Syndrome - drug therapy
Treatment Outcome
Human
Ganglioplegic
Nervous system diseases
Chemotherapy
Treatment
Efficiency
Follow up study
Antihypertensive agent
Pharmacokinetics
Neurological disorder
Mecamylamine
Online AccessGet full text

Cover

More Information
Summary:Sanberg et al report that the antihypertensive agent mecamylamine improves the symptoms of Tourette's syndrome.
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(05)60822-7